Seeing Is Believing
Currently out of the existing stock ratings of Whitney Ijem, 56 are a BUY (75.68%), 15 are a HOLD (20.27%), 3 are a SELL (4.05%).
Analyst Whitney Ijem, currently employed at CANACCORD, carries an average stock price target met ratio of 32.95% that have a potential upside of 21.49% achieved within 212 days.
Whitney Ijem’s has documented 147 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals at 01-Nov-2024.
Analyst best performing recommendations are on KRYS (KRYSTAL BIOTECH).
The best stock recommendation documented was for KRYS (KRYSTAL BIOTECH) at 6/21/2019. The price target of $48 was fulfilled within 26 days with a profit of $18.85 (64.67%) receiving and performance score of 24.87.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$182
$58.71 (47.62%)
$182
15 days ago
(21-Oct-2024)
16/48 (33.33%)
$54.69 (42.96%)
337
Buy
$165
$41.71 (33.83%)
$160
15 days ago
(21-Oct-2024)
7/9 (77.78%)
$37.69 (29.60%)
275
Buy
$205
$81.71 (66.27%)
$235
22 days ago
(14-Oct-2024)
12/24 (50%)
$80.63 (64.83%)
355
Buy
$150
$26.71 (21.66%)
26 days ago
(10-Oct-2024)
1/16 (6.25%)
$27.59 (22.54%)
659
Hold
$152
$28.71 (23.29%)
$152
1 months 16 days ago
(20-Sep-2024)
6/12 (50%)
$24.79 (19.49%)
112
Which stock is Whitney Ijem is most bullish on?
Which stock is Whitney Ijem is most reserved on?
What Year was the first public recommendation made by Whitney Ijem?